Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Indivior Pharmaceuticals' Receivables - Other history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Receivables - Other changed 0.0% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (changed 0.0% YoY), while the FY2025 annual figure was $2.0 million, changed 0.0% from the prior year.
• Receivables - Other was $2.0 million for Q4 2025 at Indivior Pharmaceuticals, roughly flat from $2.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $2.0 million in Q4 2024 to a low of $1.0 million in Q4 2023.
• Historically, Receivables - Other has averaged $1.7 million across 3 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 100.0% in 2024, then changed 0.0% in 2025.
• A 3-year view of Receivables - Other shows it stood at $1.0 million in 2023, then soared by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
• The last three Receivables - Other figures came in at $2.0 million (Q4 2025), $2.0 million (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.